Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Oruka Therapeutics, Inc. operates as a biotechnology company. The Company develops novel biologics designed for the treatment of chronic skin diseases, including plaque psoriasis and other inflammatory diseases. Oruka Therapeutics serves patients in the United States. more
Time Frame | ORKA | Sector | S&P500 |
---|---|---|---|
1-Week Return | -26.96% | 0.31% | -1.26% |
1-Month Return | -38.52% | 0.6% | -4.16% |
3-Month Return | -50% | -9.44% | -0.46% |
6-Month Return | -66.79% | -5.15% | 3.58% |
1-Year Return | -28.21% | 0.33% | 22.47% |
3-Year Return | -42.78% | 4.53% | 25.13% |
5-Year Return | -80.57% | 35.98% | 77.7% |
10-Year Return | -98.85% | 100.72% | 190.12% |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
ORKA | |
---|---|
ROA (LTM) | 0.00% |
ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
ORKA | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 0.00 |
EV/R | 0.00 |
EV/Ebitda | NM |
Oruka Therapeutics, Inc. (ORKA) share price today is $13.87
Yes, Indians can buy shares of Oruka Therapeutics, Inc. (ORKA) on Vested. To buy Oruka Therapeutics, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ORKA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Oruka Therapeutics, Inc. (ORKA) via the Vested app. You can start investing in Oruka Therapeutics, Inc. (ORKA) with a minimum investment of $1.
You can invest in shares of Oruka Therapeutics, Inc. (ORKA) via Vested in three simple steps:
The 52-week high price of Oruka Therapeutics, Inc. (ORKA) is $33. The 52-week low price of Oruka Therapeutics, Inc. (ORKA) is $10.07.
The price-to-earnings (P/E) ratio of Oruka Therapeutics, Inc. (ORKA) is
The price-to-book (P/B) ratio of Oruka Therapeutics, Inc. (ORKA) is 0.00
The dividend yield of Oruka Therapeutics, Inc. (ORKA) is 0.00%
The market capitalization of Oruka Therapeutics, Inc. (ORKA) is $485.43M
The stock symbol (or ticker) of Oruka Therapeutics, Inc. is ORKA